(Q34733983)

4 August 2017

Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition (English)

1 reference

4 August 2017

0 references

6

Ben Berkhout

0 references

author name string

Olivier ter Brake

1

1 reference

4 August 2017

Karen 't Hooft

2

1 reference

4 August 2017

Ying Poi Liu

3

1 reference

4 August 2017

Mireille Centlivre

4

1 reference

4 August 2017

Karin Jasmijn von Eije

5

1 reference

4 August 2017

15 January 2008

1 reference

4 August 2017

1 reference

4 August 2017

16

1 reference

4 August 2017

3

1 reference

4 August 2017

557-564

1 reference

The interplay between virus infection and the cellular RNA interference machinery

4 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Inhibition of respiratory viruses by nasally administered siRNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

A system for stable expression of short interfering RNAs in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Lentivirus vectors expressing short hairpin RNAs against the U3-overlapping region of HIV nef inhibit HIV replication and infectivity in primary macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Human immunodeficiency virus type 1 escape from RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Silencing of HIV-1 with RNA interference: a multiple shRNA approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Antiretroviral treatment of HIV infected adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Combinatorial RNAi: a winning strategy for the race against evolving targets?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Design of extended short hairpin RNAs for HIV-1 inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- gammac-/- mice: functional inactivation of p53 in developing T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Frequency of direct repeat deletion in a human immunodeficiency virus type 1 vector during reverse transcription in human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

High rate of recombination throughout the human immunodeficiency virus type 1 genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

RNA interference by small hairpin RNAs synthesised under control of the human 7S K RNA promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Systematic determination of the packaging limit of lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

An essential role for LEDGF/p75 in HIV integration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Promoter choice affects the potency of HIV-1 specific RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Poly(U) and polyadenylation termination signals are interchangeable for terminating the expression of shRNA from a pol II promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Experimental models to study development and function of the human immune system in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Current status of gene therapy strategies to treat HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Gene therapy progress and prospects: novel gene therapy approaches for AIDS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Gene transfer in humans using a conditionally replicating lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300382

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300382

1 reference

4 August 2017

1 reference